Accuracy of MRI and ultrasonography in predicting pathologic complete response in breast cancer patients treated with neoadjuvant chemotherapy

被引：0
|
作者：
Hayashi, N.
Tsunoda, H.
Matsuda, N.
Nakamura, S.
Tsugawa, K.
Akiyama, F.
Takahashi, Y.
Yoshida, A.
Yagata, H.
Suzuki, K.
Yamauchi, H.
机构：
[1] St Lukes Int Hosp, Tokyo, Japan
[2] Showa Univ, Sch Med, Tokyo 142, Japan
[3] St Marianna Univ, Sch Med, Tokyo, Japan
[4] Japanese Fdn Canc Res, Canc Inst Hosp, Tokyo, Japan
来源：
CANCER RESEARCH | 2013年 / 73卷
关键词：
D O I：
10.1158/0008-5472.SABCS13-P2-02-11
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2-02-11
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Nomogram-derived prediction of pathologic complete response (pCR) in breast cancer patients treated with neoadjuvant chemotherapy (NCT)
    Shengyu Pu
    Ke Wang
    Yang Liu
    Xiaoqin Liao
    Heyan Chen
    Jianjun He
    Jian Zhang
    BMC Cancer, 20
  • [42] Methodological issues in radiomics: impact on accuracy of MRI for predicting response to neoadjuvant chemotherapy in breast cancer
    Netti, Sofia
    D'Ecclesiis, Oriana
    Corso, Federica
    Botta, Francesca
    Origgi, Daniela
    Pesapane, Filippo
    Agazzi, Giorgio Maria
    Rotili, Anna
    Gaeta, Aurora
    Scalco, Elisa
    Rizzo, Giovanna
    Jereczek-Fossa, Barbara Alicja
    Cassano, Enrico
    Curigliano, Giuseppe
    Gandini, Sara
    Raimondi, Sara
    EUROPEAN RADIOLOGY, 2024,
  • [43] Effective factors to raise diagnostic performance of breast MRI for diagnosing pathologic complete response in breast cancer patients after neoadjuvant chemotherapy
    Choi, Bo Bae
    Kim, Sung Hun
    ACTA RADIOLOGICA, 2015, 56 (07) : 790 - 797
  • [44] Delta-Radiomics Based on Dynamic Contrast-Enhanced MRI Predicts Pathologic Complete Response in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy
    Guo, Liangcun
    Du, Siyao
    Gao, Si
    Zhao, Ruimeng
    Huang, Guoliang
    Jin, Feng
    Teng, Yuee
    Zhang, Lina
    CANCERS, 2022, 14 (14)
  • [45] Inflammatory Markers Predicting Pathological Complete Response in Cases with Breast Cancer Treated by Neoadjuvant Chemotherapy
    Buyuksimsek, Mahmut
    Ogul, Ali
    Mirilli, Cem
    Paydas, Semra
    EUROPEAN JOURNAL OF BREAST HEALTH, 2020, 16 (04) : 229 - 234
  • [46] Clinical and pathologic predictors of complete pathologic response to neoadjuvant docetaxel/anthracycline chemotherapy in breast cancer patients.
    Coplin, M
    Naughton, M
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 85S - 85S
  • [47] Treatment response evaluation by MRI in breast cancer patients receiving neoadjuvant chemotherapy: there is more than just pathologic complete response prediction
    Lobbes, M. B. I.
    BREAST CANCER RESEARCH AND TREATMENT, 2012, 136 (01) : 313 - 314
  • [48] Treatment response evaluation by MRI in breast cancer patients receiving neoadjuvant chemotherapy: there is more than just pathologic complete response prediction
    M. B. I. Lobbes
    Breast Cancer Research and Treatment, 2012, 136 : 313 - 314
  • [49] Tailoring neoadjuvant chemotherapy for patients with breast cancer who have achieved pathologic complete response
    Li, Xianjun
    Liu, Yang
    Shan, Ming
    Xu, Biagqi
    Lu, Yubo
    Zhang, Guoqiang
    TRANSLATIONAL CANCER RESEARCH, 2020, 9 (02) : 1205 - 1214
  • [50] Survival and recurrence of breast cancer patients with pathologic complete response after neoadjuvant chemotherapy.
    Lee, Young Joo
    Ahn, Sei-Hyun
    Sohn, Byung Ho
    Lee, Jong Won
    Chung, Il Yong
    Ko, Beom Seok
    Kim, Hee Jeong
    Kim, Jisun
    Lee, Sae Byul
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
12345